Diffusion Pharmaceuticals is a biopharmaceutical company that has created an innovative product designed to improve the delivery of oxygen to the body's tissues. This product, named Trans Sodium Crocetinate, has shown promise in treating COVID-19 patients. The company is based in Charlottesville, Virginia and was established in 2001.